| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,378 |
7,556 |
$188K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,235 |
4,773 |
$134K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,491 |
1,318 |
$49K |
| 99000 |
|
5,011 |
4,594 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,581 |
2,169 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,208 |
694 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
618 |
580 |
$6K |
| 93000 |
|
898 |
865 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
61 |
59 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
235 |
232 |
$2K |
| 81003 |
|
3,084 |
2,768 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
64 |
63 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
16 |
15 |
$1K |
| 90686 |
|
167 |
162 |
$1K |
| 90674 |
|
100 |
98 |
$911.64 |
| 99497 |
|
18 |
18 |
$551.53 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,178 |
971 |
$504.75 |
| 90688 |
|
63 |
62 |
$448.94 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
50 |
29 |
$384.16 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
12 |
$354.18 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
46 |
46 |
$289.21 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
621 |
540 |
$253.79 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
239 |
239 |
$236.05 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
67 |
65 |
$176.50 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
202 |
172 |
$53.63 |
| 90756 |
|
55 |
55 |
$45.50 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
76 |
75 |
$30.21 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
52 |
52 |
$20.95 |
| 80061 |
Lipid panel |
101 |
94 |
$12.28 |
| 82947 |
|
88 |
85 |
$7.53 |
| 36415 |
Collection of venous blood by venipuncture |
4,637 |
4,328 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
141 |
141 |
$0.00 |
| 3074F |
|
351 |
321 |
$0.00 |
| 3079F |
|
98 |
97 |
$0.00 |
| 81000 |
|
14 |
13 |
$0.00 |
| 3075F |
|
29 |
29 |
$0.00 |
| 3044F |
|
44 |
38 |
$0.00 |
| 92567 |
|
18 |
12 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
14 |
14 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
21 |
20 |
$0.00 |
| 3078F |
|
347 |
310 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
14 |
14 |
$0.00 |